Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation

Clinical trial NCT00167310 · COMPLETED

Trial details

NCT number: NCT00167310
Sponsor: University of Pittsburgh
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Major Depression Bipolar Disorder Coronary Artery Disease

Start date: 2005-09-01
Primary completion: 2015-12-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.